Part 2 of 4.
My guest for this week’s episode is Jacob Glanville. Jacob is the Founder, CEO, & President of Centivax and was formerly the Co-founder, CEO, and President of Distributed Bio.
Join us as we sit down with Jake, discussing his time at Rinat Labs, a Pfizer company, and how he found a way to leverage his skills and experience to create new bioinformatic processes.
Learn more about his initial idea for a universal vaccine and why he chose to pursue a PhD at Stanford. Hear Jake’s view on how to be excited about what you do, and leveraging that excitement to pursue your goals, entrepreneurial or otherwise.
Please enjoy my conversation with Jake Glanville.
Find Our Guest, Jacob Glanville, at these links:
Find Our Host, Jon Chee, at these links:
Social & Website
Timestamps:
00:00 Intro
01:49 Episode start
03:42 Finding how to make yourself most useful
05:22 Why Big Pharma buys small biotechs
07:00 A lack of bioinformatic tools and solving for that issue
09:29 Collecting data on experiments and conducting meta-analysis
11:08 Analyzing antibody libraries and mice immunizations
12:14 Synthesizing the data to better understand antibodies and vaccination
14:09 Leaving Rinat/Pfizer, the idea of a universal vaccine
16:06 Getting a PhD and launching a company simultaneously
21:03 Starting Distributed Bio and navigating time at Stanford
25:29 Find out what makes you excited and pursue it
27:43 Tech transfer and keeping DB and Stanford work separate
30:08 Outro
Enriched Notes:
Topics Mentioned:
People Mentioned:
The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.
